Annual CFO
-$12.81 M
-$919.50 K-7.73%
December 31, 2023
Summary
- As of February 8, 2025, KTTA annual cash flow from operations is -$12.81 million, with the most recent change of -$919.50 thousand (-7.73%) on December 31, 2023.
- KTTA annual CFO is now -303.71% below its all-time high of -$3.17 million, reached on December 31, 2021.
Performance
KTTA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$3.12 M
+$918.40 K+22.74%
September 30, 2024
Summary
- As of February 8, 2025, KTTA quarterly cash flow from operations is -$3.12 million, with the most recent change of +$918.40 thousand (+22.74%) on September 30, 2024.
- Over the past year, KTTA quarterly CFO has increased by +$918.40 thousand (+22.74%).
- KTTA quarterly CFO is now -717.31% below its all-time high of -$381.80 thousand, reached on March 31, 2021.
Performance
KTTA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$14.18 M
+$128.60 K+0.90%
September 30, 2024
Summary
- As of February 8, 2025, KTTA TTM cash flow from operations is -$14.18 million, with the most recent change of +$128.60 thousand (+0.90%) on September 30, 2024.
- Over the past year, KTTA TTM CFO has increased by +$128.60 thousand (+0.90%).
- KTTA TTM CFO is now -3614.12% below its all-time high of -$381.80 thousand, reached on March 31, 2021.
Performance
KTTA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
KTTA Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -7.7% | +22.7% | +0.9% |
| 3 y3 years | - | +26.1% | -35.6% |
| 5 y5 years | - | +26.1% | -35.6% |
KTTA Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -303.7% | at low | -78.9% | +27.8% | -346.8% | +0.9% |
| 5 y | 5-year | -303.7% | at low | -717.3% | +27.8% | -3614.1% | +0.9% |
| alltime | all time | -303.7% | at low | -717.3% | +27.8% | -3614.1% | +0.9% |
Pasithea Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$3.12 M(-22.7%) | -$14.18 M(-0.9%) |
| Jun 2024 | - | -$4.04 M(-6.5%) | -$14.31 M(+4.1%) |
| Mar 2024 | - | -$4.32 M(+60.0%) | -$13.75 M(+7.3%) |
| Dec 2023 | -$12.81 M(+7.7%) | -$2.70 M(-16.9%) | -$12.81 M(-3.6%) |
| Sep 2023 | - | -$3.25 M(-6.6%) | -$13.30 M(-6.8%) |
| Jun 2023 | - | -$3.48 M(+2.8%) | -$14.27 M(+12.2%) |
| Mar 2023 | - | -$3.39 M(+6.3%) | -$12.72 M(+6.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$11.89 M(+274.7%) | -$3.19 M(-24.5%) | -$11.89 M(+13.8%) |
| Sep 2022 | - | -$4.22 M(+119.3%) | -$10.45 M(+54.2%) |
| Jun 2022 | - | -$1.92 M(-24.9%) | -$6.78 M(+26.6%) |
| Mar 2022 | - | -$2.56 M(+47.0%) | -$5.36 M(+68.7%) |
| Dec 2021 | -$3.17 M | -$1.74 M(+218.1%) | -$3.17 M(+122.0%) |
| Sep 2021 | - | -$548.40 K(+9.8%) | -$1.43 M(+62.2%) |
| Jun 2021 | - | -$499.40 K(+30.8%) | -$881.20 K(+130.8%) |
| Mar 2021 | - | -$381.80 K | -$381.80 K |
FAQ
- What is Pasithea Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Pasithea Therapeutics?
- What is Pasithea Therapeutics annual CFO year-on-year change?
- What is Pasithea Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Pasithea Therapeutics?
- What is Pasithea Therapeutics quarterly CFO year-on-year change?
- What is Pasithea Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Pasithea Therapeutics?
- What is Pasithea Therapeutics TTM CFO year-on-year change?
What is Pasithea Therapeutics annual cash flow from operations?
The current annual CFO of KTTA is -$12.81 M
What is the all time high annual CFO for Pasithea Therapeutics?
Pasithea Therapeutics all-time high annual cash flow from operations is -$3.17 M
What is Pasithea Therapeutics annual CFO year-on-year change?
Over the past year, KTTA annual cash flow from operations has changed by -$919.50 K (-7.73%)
What is Pasithea Therapeutics quarterly cash flow from operations?
The current quarterly CFO of KTTA is -$3.12 M
What is the all time high quarterly CFO for Pasithea Therapeutics?
Pasithea Therapeutics all-time high quarterly cash flow from operations is -$381.80 K
What is Pasithea Therapeutics quarterly CFO year-on-year change?
Over the past year, KTTA quarterly cash flow from operations has changed by +$918.40 K (+22.74%)
What is Pasithea Therapeutics TTM cash flow from operations?
The current TTM CFO of KTTA is -$14.18 M
What is the all time high TTM CFO for Pasithea Therapeutics?
Pasithea Therapeutics all-time high TTM cash flow from operations is -$381.80 K
What is Pasithea Therapeutics TTM CFO year-on-year change?
Over the past year, KTTA TTM cash flow from operations has changed by +$128.60 K (+0.90%)